Financings in Brief: Poly U/A Systems Inc./IRIS
This article was originally published in The Gray Sheet
Executive Summary
Poly U/A Systems Inc./IRIS: PSI completes $2.6 mil. private financing to fund development of new urinalysis products in a joint program with International Remote Imaging Systems. IRIS has committed about $500,000 of its own funds to the program. Products to be developed will be based on IRIS' technology and are expected include both "stand-alone products and enhancements to the IRIS flagship product, The Yellow IRIS urinalysis workstation," IRIS says. Under terms of the deal, newly formed Chatsworth, California-based PSI will have the right to sell stand-alone products developed through the program; IRIS will have the right to incorporate the new products into The Yellow IRIS. IRIS will conduct R&D, clinical evaluation and pre-market testing. The first product introduction from the joint program is expected in 1997.
You may also be interested in...
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.